(Q44249438)

1 December 2017

title

Patterns of oxidized epitopes, but not NF-kappa B expression, change during atherogenesis in WHHL rabbits (English)

1 reference

1 December 2017

0 references

5

1 reference

1 December 2017

2

Tomi Häkkinen

1 reference

1 December 2017

Jan Hinrich Bräsen

1

1 reference

1 December 2017

Ernst Malle

series ordinal

3

1 reference

1 December 2017

Ulrike Beisiegel

series ordinal

4

1 reference

1 December 2017

publication date

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

volume

166

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

13-21

1 reference

Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Low density lipoprotein undergoes oxidative modification in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Presence of hypochlorite-modified proteins in human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Hypochlorite-modified (lipo)proteins are present in rabbit lesions in response to dietary cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Transfer of 15-lipoxygenase gene into rabbit iliac arteries results in the appearance of oxidation-specific lipid-protein adducts characteristic of oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Is NF-kappaB the sensor of oxidative stress?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Conservation of the low density lipoprotein receptor-binding domain of apoprotein B. Demonstration by a new monoclonal antibody, MB47

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900130-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0021-9150(02)00130-2

1 reference

1 December 2017

1 reference